In a 15 chapter docuseries, the Huffington Post described the inner-makings of big pharma, specifically Johnson & Johnson’s manufacture and sale of its anti-psychotic drug, Risperdal. The docuseries has a number of insights about this business, including this piece:
In describing how a Wall Street financial analyst disregarded a recent multi-million dollar verdict against the company for Risperdal causing a young boy to grow female breasts, the series author describes the analyst as saying: “All the big pharma” have lawsuits, the analyst concluded, sipping an espresso, “It’s just not a big deal.” Big pharma chalks this up to the cost of doing business. The article describes that with $20.6 billion in profits in 2014, setting aside $500 million or even $1 billion a year to cover payouts for boys deformed by this drug doesn’t put much of a dent in the company’s financials.
To learn more about the business of big pharma and the Risperdal litigation, the full docuseries can be found at this website: https://highline.huffingtonpost.com/miracleindustry/americas-most-admired-lawbreaker/
I serve on the Plaintiffs’ Steering Committee of the California consolidation of Risperdal cases. I also actively represent hundreds of male plaintiffs who allege they grew enlarged female breasts from the drug Risperdal. I have represented victims of big pharma for years. Parts of the docuseries mentioned above ring true based on my experience litigating these cases. If you or a loved one has suffered injury from Risperdal or another pharmaceutical, please contact me. I would be happy to talk to you about your experience.